英集芯称脑机接口相关芯片量产出货，性能参数媲美海外头部产品 收监管函后马上改口：还没规模化销售

Core Viewpoint - The brain-computer interface (BCI) concept is gaining traction, with several listed companies, including Yingjixin, capitalizing on this trend through product announcements and strategic investments [1][2]. Group 1: Company Developments - Yingjixin announced the launch of the IPA1299 chip, a low-noise, 8-channel, 24-bit synchronous sampling analog-to-digital converter (ADC) designed for applications in electroencephalography (EEG), electrocardiography (ECG), and electromyography (EMG) [1]. - The IPA1299 chip is noted for its high-precision signal acquisition capabilities, making it suitable for non-invasive BCI applications, which differ significantly from current invasive BCI technologies [1]. - The company holds a 15% stake in its partner, Precision Weir (Changzhou) Electronics Technology Co., Ltd., which was established in September 2023 with a registered capital of 1.1765 million yuan [1]. Group 2: Market Position and Financials - Yingjixin's revenue for the first three quarters of 2025 was reported at 1.169 billion yuan, with a net profit attributable to shareholders of 114 million yuan [2]. - The company indicated that the BCI product is still in the market cultivation phase and has not yet achieved significant sales, leading to uncertainty regarding future sales performance [1].